Based on the novel mechanism of ablation of the Notch1‐p15‐mediated tumor suppression in AML hyperproliferation, targeting ANXA1 provides an effective approach for AML treatment, in which antagonizing ANXA1 using NICD inhibitory peptides is an effective strategy for AML treatment. The gene discussed is CDKN2B; the disease is neoplasm.